NCT04578548Phase 2Terminated

A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Study sponsor: Lakefront Biotherapeutics NV · LKFT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-12-14Actual
Enrollment · participants66Actual
Source updated2024-08-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview